CYCLERION THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
CYCLERION THERAPEUTICS, INC. (CYCN) had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-05
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-06-30: Operating Lease, Right-of-Use Asset $1.13M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $1.17M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.13M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $1.17M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-05 |
| 2022-09-30 | $1.26M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.31M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.36M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.40M 10-K · filed 2023-03-22 |
| 2021-09-30 | $1.45M 10-Q · filed 2021-11-09 |
| 2021-03-31 | $42.40M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $43.40M 10-K · filed 2022-02-24 |
| 2020-09-30 | $44.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $51.31M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $52.25M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $68.14M 10-K · filed 2021-02-25 |
| 2019-09-30 | $69.16M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $70.33M 10-Q · filed 2019-08-12 |
| 2019-04-01 | $71.30M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |